NCT01030835

Brief Summary

Background: \- The National Institute of Drug Abuse (NIDA) is interested in developing a pool of potential research participants who may be eligible for research studies on drug abuse and addiction, pharmacological and psychosocial therapies for substance addiction, drug abuse and co-occurring psychiatric disorders, and the long-term effects of drugs on the development, function, and structure of the brain and other organ systems. To develop this pool of potential participants, researchers intend to screen individuals who may be eligible for future research studies. Objectives: \- To identify, recruit, and screen participants for NIDA collaborative research protocols. Eligibility: \- Individuals 18 years of age and older who are able to provide informed consent. Design:

  • Eligible participants will undergo two screening interviews: a telephone interview and an in-person interview. The phone interview will determine eligibility for the in-person interview.
  • The in-person interview, which may require up to five visits to the clinical center, will involve any or all of the following procedures: (1) full physical examination and medical history; (2) psychiatric interview; (3) psychological testing; (4) electrocardiogram; (5) samples of blood, urine, and hair; and (6) other minimally invasive procedures as directed by the research staff.
  • Participants will provide a photograph for confirmation of identity for subsequent visits and protocols.
  • No clinical care will be provided under this protocol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2009

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 28, 2009

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

December 11, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 14, 2009

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2012

Completed
Last Updated

July 2, 2017

Status Verified

April 10, 2012

First QC Date

December 11, 2009

Last Update Submit

June 30, 2017

Conditions

Keywords

Screening ProtocolComorbidityNormal ControlsSubstance Use DisordersSubstance Abuse Disorders

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (at least age 18)
  • Ability to understand and answer the questions posed

You may not qualify if:

  • \. Inability to provide valid informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

National Institute on Drug Abuse, Biomedical Research Center (BRC)

Baltimore, Maryland, 21224, United States

Location

Maryland Psychiatric Research Center (MPRC) 55 Wade Avenue

Catonsville, Maryland, 21228, United States

Location

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Study Officials

  • David A Gorelick, M.D.

    National Institute on Drug Abuse (NIDA)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
OTHER
Sponsor Type
NIH

Study Record Dates

First Submitted

December 11, 2009

First Posted

December 14, 2009

Study Start

May 28, 2009

Study Completion

April 10, 2012

Last Updated

July 2, 2017

Record last verified: 2012-04-10

Locations